Dedicated to immunity, cognitive functions and relaxation — Rritual Superfoods product line to hit the USA in Q2
Natural based products that can boost our physical and mental well-being are becoming increasingly popular. The public is learning that spending on health and reducing disease is a wise move both financially and for your long term health and happiness.
By 2025, the global health and wellness market is forecast to have revenues of over US$6 trillion, up 36% from US$4.4 trillion in 2019.
One company tapping into this emerging health and wellness market is Rritual Superfoods Inc. (CSE: RSF) (“Rritual”). Rritual is dedicated to using functional mushrooms and herbs combined to help clients with immunity, cognitive/brain function, and relaxation.
Rritual Superfoods are made from natural herbs and medicines with hundreds of years of history. Rritual combines functional mushroom and adaptogens to create plant-based elixirs. Adaptogens are non-toxic herbs, roots, and fungi that work to increase your body’s ability to resist stressors, restoring the body to its normal or optimal function.
Why buy Rritual Superfoods?
“Our small batch elixirs are made with limited, yet very purposeful and organic ingredients — beginning with naturally harvested mushrooms, herbal spices like cinnamon and ginger, and whole foods like coconut + fruit powders to create blends that are as delicious as they are beneficial.”
Rritual Superfoods is just beginning to commercialize their products in the USA
Rritual Superfoods is launching in North America in Q2 2021 as the company positions itself as a leader in the functional health and wellness industry. This is good news for investors as successful commercialization potentially leads to rapidly growing revenues and profits. This also potentially leads to stock price appreciation as the market re-rates a company.
Rritual Superfoods products for cognitive, immune, and stress/sleep support
Rritual CEO David Kerbel recently stated in an exclusive interview with InvestorIntel that “functional mushrooms have been around for 2000 years and Rritual has taken it to the next level by adding the adaptogens….We are right on the cusp of becoming that premium brand in the space….”
It is also interesting to note that functional mushrooms are a Top-10 rated food in the $275 billion functional food market.
More about the company’s rapid progress since recently listing on the CSE
Rritual Superfoods only listed on the CSE in March 8, 2021 so their story is still very new. Then on March 11 Rritual announced their launch of a U.S. facing e-commerce website Rritual.com. With the announcement came the news that Rritual’s Reishi Relax products won a ECRM Buyer’s Choice Award at the ‘Whole Body & Mind Wellness’ virtual trade show. On March 17 Rritual announced that they had completed a second commercial scale manufacturing run. This is an important step to support their Q2 2021 U.S. product launch. Then on March 30 Rritual announced: “Rritual Superfoods to launch product line in Rite Aid Stores nationwide….throughout the USA in Q2 and Q3.” What a month of tremendous news flow!
CEO Kerbel stated:
“To meet expected demand, we have ramped up securing raw materials and scheduled commercial scale production runs. Maintaining a consistent and scalable manufacturing cycle is a core focus as we look forward to bringing our products to the major retailer shelves soon. Our team has been carefully and methodically building our logistics infrastructure which will allow for not only our needs today but also will allow us to achieve sustainable growth into the future.”
If the COVID-19 pandemic has taught us anything, it is that we need to look after our health, especially our immune system, and our mental and physical well-being.
Rritual Superfoods is just beginning their journey to tap into the health and wellness market, a global market that is forecast to grow from about US$4.4 trillion to US$6 trillion in the next 5 years.
Rritual Superfoods currently trades on a market cap of just C$34 million and looks to be worth following closely as they make their launch into the U.S starting in Q2, 2021.
Matthew Bohlsen is a Senior Editor for InvestorIntel.com. With a Graduate Diploma in Applied Finance and Investment, and a Graduate Diploma in Financial Planning. He ... <Read more about Matthew Bohlsen>